Shujun Lin

1.9k total citations · 1 hit paper
49 papers, 1.4k citations indexed

About

Shujun Lin is a scholar working on Molecular Biology, Nephrology and Genetics. According to data from OpenAlex, Shujun Lin has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Nephrology and 7 papers in Genetics. Recurrent topics in Shujun Lin's work include Mesenchymal stem cell research (6 papers), Renal Diseases and Glomerulopathies (4 papers) and Ubiquitin and proteasome pathways (4 papers). Shujun Lin is often cited by papers focused on Mesenchymal stem cell research (6 papers), Renal Diseases and Glomerulopathies (4 papers) and Ubiquitin and proteasome pathways (4 papers). Shujun Lin collaborates with scholars based in China, Canada and United States. Shujun Lin's co-authors include Juergen Kast, Tian‐Biao Zhou, Melissa R. Junttila, Pietri Puustinen, Jukka Westermarck, Fábio Rossi, Xiao‐Jing Wang, Christina Nielsen, Trine Bøttzauw and Minna Niemelä and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Shujun Lin

47 papers receiving 1.4k citations

Hit Papers

CIP2A Inhibits PP2A in Human Malignancies 2007 2026 2013 2019 2007 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shujun Lin China 16 822 354 206 179 171 49 1.4k
Susana Constantino Rosa Santos Portugal 17 664 0.8× 464 1.3× 105 0.5× 250 1.4× 224 1.3× 41 1.3k
Toshiyuki Kitano Japan 18 782 1.0× 536 1.5× 191 0.9× 129 0.7× 234 1.4× 70 1.6k
Bartosz Puła Poland 23 724 0.9× 505 1.4× 168 0.8× 282 1.6× 170 1.0× 138 1.6k
Anna Garuti Italy 21 644 0.8× 477 1.3× 117 0.6× 254 1.4× 297 1.7× 67 1.5k
Ya‐Sian Chang Taiwan 21 700 0.9× 251 0.7× 160 0.8× 388 2.2× 102 0.6× 71 1.2k
Patrícia A. Madureira Portugal 21 1.1k 1.4× 293 0.8× 137 0.7× 512 2.9× 295 1.7× 29 1.7k
Hui Lin Chua United States 19 494 0.6× 394 1.1× 259 1.3× 297 1.7× 146 0.9× 29 1.3k
Qi Xue China 13 1.0k 1.3× 300 0.8× 353 1.7× 391 2.2× 125 0.7× 34 1.5k
Maria Concetta Faniello Italy 22 719 0.9× 182 0.5× 194 0.9× 361 2.0× 76 0.4× 55 1.2k

Countries citing papers authored by Shujun Lin

Since Specialization
Citations

This map shows the geographic impact of Shujun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shujun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shujun Lin more than expected).

Fields of papers citing papers by Shujun Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shujun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shujun Lin. The network helps show where Shujun Lin may publish in the future.

Co-authorship network of co-authors of Shujun Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shujun Lin. A scholar is included among the top collaborators of Shujun Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shujun Lin. Shujun Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaofang, Jian Lü, Xiaoyu Zhang, et al.. (2025). Effects of Angiotensin II Receptor 1 Inhibition by LCZ696 on the Acquisition and Relapse of Methamphetamine-Associated Contextual Memory. Pharmaceuticals. 18(7). 1016–1016.
2.
Lin, Shujun, et al.. (2024). Inhibition of GSDMD-dependent pyroptosis decreased methamphetamine self-administration in rats. Brain Behavior and Immunity. 120. 167–180. 2 indexed citations
3.
Lin, Shujun, et al.. (2024). The neuroprotective effect of LCZ696 on methamphetamine-induced cognitive impairment in mice. Neuroscience Letters. 823. 137630–137630. 4 indexed citations
4.
Yang, Xiangdong, et al.. (2024). The effect of paeoniflorin on the rewarding effect of methamphetamine and the associated cognitive impairment in mice. Metabolic Brain Disease. 40(1). 27–27. 2 indexed citations
5.
Si, Zizhen, et al.. (2023). EGCG attenuates METH self‐administration and reinstatement of METH seeking in mice. Addiction Biology. 28(8). e13307–e13307. 1 indexed citations
6.
Wang, Linpei, et al.. (2023). USP33 enhances cell survival and stemness by deubiquitinating CTNNB1 in BXPC‐3 and SW1990 cells. Cell Biology International. 47(8). 1368–1380. 4 indexed citations
7.
Wang, Jiali, et al.. (2022). Influencing factors of serum magnesium in CKD5 patients: A multicenter study in southern China. Frontiers in Public Health. 10. 1047602–1047602. 1 indexed citations
9.
Zhou, Tian‐Biao, et al.. (2020). Association of apoE gene polymorphisms with lipid metabolism in renal diseases. African Health Sciences. 20(3). 1368–1381. 4 indexed citations
10.
Jiang, Xuefeng, et al.. (2020). Aloe‐Emodin Induces Breast Tumor Cell Apoptosis through Upregulation of miR‐15a/miR‐16‐1 That Suppresses BCL2. Evidence-based Complementary and Alternative Medicine. 2020(1). 5108298–5108298. 22 indexed citations
11.
Zhou, Tian‐Biao, et al.. (2020). Efficacy of mesenchymal stem cells in animal models of lupus nephritis: a meta-analysis. Stem Cell Research & Therapy. 11(1). 48–48. 30 indexed citations
12.
Tvorogov, Denis, Shujun Lin, Jürgen Kast, et al.. (2020). The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration. Journal of Biological Chemistry. 295(33). 11559–11571. 12 indexed citations
13.
Lin, Shujun, et al.. (2019). <p>Efficacy and safety of cyclosporine A in the treatment of idiopathic membranous nephropathy in an Asian population</p>. Drug Design Development and Therapy. Volume 13. 2305–2330. 11 indexed citations
15.
Hong, Chien‐Hui, et al.. (2018). 151 CCL21 induces mTOR-dependent malat-1 expression, leading to cell migration in cutaneous T cell lymphoma. Journal of Investigative Dermatology. 138(5). S26–S26.
16.
Su, Le, Arthur V. Sampaio, Kevin B. Jones, et al.. (2012). Deconstruction of the SS18-SSX Fusion Oncoprotein Complex: Insights into Disease Etiology and Therapeutics. Cancer Cell. 21(3). 333–347. 115 indexed citations
17.
Puustinen, Pietri, Melissa R. Junttila, Sari Vanhatupa, et al.. (2009). PME-1 Protects Extracellular Signal-Regulated Kinase Pathway Activity from Protein Phosphatase 2A–Mediated Inactivation in Human Malignant Glioma. Cancer Research. 69(7). 2870–2877. 81 indexed citations
18.
Gossens, Klaus, Silvia Naus, Stéphane Y. Corbel, et al.. (2009). Thymic progenitor homing and lymphocyte homeostasis are linked via S1P-controlled expression of thymic P-selectin/CCL25. The Journal of Experimental Medicine. 206(4). 761–778. 86 indexed citations
19.
Lin, Shujun, et al.. (2008). Implementation of a data repository-driven approach for targeted proteomics experiments by multiple reaction monitoring. Journal of Proteomics. 72(5). 838–852. 31 indexed citations
20.
Junttila, Melissa R., Pietri Puustinen, Minna Niemelä, et al.. (2007). CIP2A Inhibits PP2A in Human Malignancies. Cell. 130(1). 51–62. 533 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026